甲代谢和细胞染色体P450多态性:一个系统的审查和元分析
Seenae Eum1, Nicholas P Vernacchia2, Nia Doughty2
1Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, MO, USA.
Expert opinion on drug metabolism & toxicology
|November 28, 2024
概括
在CYP2B6的遗传变异显著影响甲的代谢,影响 (S) - 甲的度和清除. 这些CYP2B6 (cytochrome P450 2B6) 遗传多态性影响甲的剂量,但不影响临床结果.
科学领域:
- 药物基因组学 药物基因组学
- 临床药理学 临床药理学
- 药物新陈代谢 药物新陈代谢
背景情况:
- 甲是阿片类药物使用障碍和疼痛管理的关键药物.
- 了解影响甲代谢的因素对于优化临床疗效和安全至关重要.
- 细胞染色体P450 (CYP) 酶在药物代谢中发挥着重要作用,包括甲.
研究的目的:
- 系统地审查和综合关于CYP遗传多态化对甲结局影响的证据.
- 为了澄清有关甲代谢及其临床影响的现有混.
主要方法:
- 一个全面的系统审查和对研究CYP多态性和甲结局的研究的元分析.
- 在主要的科学数据库中进行了搜索 (MEDLINE,EMBASE,科学网,PsycINFO,CENTRAL).
- 使用ROBINS-I评估偏差风险和使用平均值或赔率比率的综合数据.
主要成果:
- 该CYP2B6c.516G>T变体显著影响了 (S) - 甲的度和清除,对 (R) - 或 (R,S) - 甲的影响较小.
- 这种CYP2B6变体在阿片类药物使用障碍中显示出与甲剂量具有统计学意义的关联.
- 在CYP2C19,CYP2C9,CYP2D6和CYP3A5中的多态性对评估的甲结局没有显著影响.
结论:
- CYP2B6的遗传变异显然影响了 (S) - 甲的暴露和清除.
- 虽然与剂量相关,但CYP2B6基因对甲剂量要求的影响并不具有临床意义.
- 进一步的研究可能会完善对CYP2B6在甲药物遗传学中的作用的理解.
相关概念视频
Factors Affecting Drug Biotransformation: Biological
112
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
112
Drug Metabolism: Phase I Reactions
3.1K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.1K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
84
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
84
Drug Metabolism: Phase II Reactions
3.7K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.7K
Phase II Reactions: Methylation Reactions
136
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
136
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
187
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
187


